Newstral
Office of New Drugs
- FDA Establishes CDER Center for Clinical Trial Innovation (C3TI)jdsupra.com
- Getting START’ed: New FDA programs aim to advance drugs to treat rare diseasesjdsupra.com
- Can We Still Be Friends? FDA Issues Draft Guidance on Formal Dispute Resolution and Administrative Hearings of Final Administrative Orders Relating to OTC Monograph Drugsjdsupra.com
- House Dems raise issues with ‘atypical’ FDA review process for Alzheimer’s drugPOLITICO
- Expert advisers urge FDA to pull pregnancy drug Makena from marketAlaska Dispatch News
- A Focal Point for FDA’s Rare Diseases Efforts: CDER’s New ARC Programjdsupra.com
- Ushering in a New Era: FDA Approves First Interchangeable Biosimilarjdsupra.com
- BTop FDA Staffers Defend Approval of Biogen's Alzheimer's Drug 4 min readbarrons.com
- New drug could dramatically reduce cholesterolUSA today
- New cholesterol drug may reduce heart attacks, strokesgadsdentimes.com
- FDA approves drug that eventually could help half of people with cystic fibrosisWashington Post
- Should I Still Take Contrave?WHIO
- A Top Cardiologist Says A Diet Drug Maker Misled PatientsForbes
- FDA approves first lower-cost biotech drugthedailyrecord.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.